Erythroid Leukemia

• CLINICAL_TRIALS trial_result · 2026-04-13
  Clinical Trial Update: Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia [Phase 1, Phase 2]

  This clinical trial update reports a Phase 1/2 study of the combination of vorinostat and azacitidine in patients with myelodysplastic syndr…

• CLINICAL_TRIALS trial_result · 2025-01-01
  Clinical Trial Update: Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers [Phase 2]

  Phase 2 trial evaluating cord blood transplant with Dilanubicel for HIV-positive hematologic cancers; the study was terminated and results w…

• CLINICAL_TRIALS trial_result · 2023-11-07
  Clinical Trial Update: Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid Malignancies [Phase 1, Phase 2]

  Phase 1/2 clinical trial evaluating donor natural killer cells and donor stem cell transplant in high-risk myeloid malignancies; completed w…

• CLINICAL_TRIALS trial_result · 2022-10-26
  Clinical Trial Update: Efficacy and Safety of HVA Regimens as Salvage Treatment in rrAML [Phase 2]

  Phase 2 trial evaluating HVA regimens as salvage therapy for refractory/relapsed acute myeloid leukemia and related erythroid leukemias; stu…

• CLINICAL_TRIALS withdrawal · 2017-10-19
  Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission [Phase 2]

  A Phase 2 trial evaluating donor stem cell transplant for adults with acute myeloid leukemia in remission has been withdrawn.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2016-08-10
  Clinical Trial Update: Molecular Characterization of Acute Erythroid Leukemia (M6-AML) Using Targeted Next-generation Sequencing

  Clinical trial update detailing the molecular characterization of acute erythroid leukemia (M6-AML) using targeted next-generation sequencin…

• CLINICAL_TRIALS trial_result · 2013-02-05
  Clinical Trial Update: Bortezomib, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia [Phase 1, Phase 2]

  This update reports on a Phase 1/2 clinical trial evaluating the combination of bortezomib, daunorubicin, and cytarabine in older patients w…